Partner Content Partner Content Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist... 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content Exclusive insights into the latest innovations at Drug Disco... Exclusive insights into the latest innovations
Partner Content Partner Content New Speakers from Roche & Imperial College announced for... Roche to join ADMET conference this July in London
Partner Content Partner Content Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snippet fo... Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snipp
News Disappointment for BMS as Zeposia fails Crohn’s study Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.